These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 18342927)

  • 1. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?
    Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA
    Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of bcl-2 and bcl-X in bladder cancer.
    Kirsh EJ; Baunoch DA; Stadler WM
    J Urol; 1998 Apr; 159(4):1348-53. PubMed ID: 9507882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer.
    Khaled H; El Hattab O; Moneim DA; Kassem HA; Morsi A; Sherif G; Darwish T; Gaafar R
    Urol Oncol; 2005; 23(4):254-60. PubMed ID: 16018940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of prognostic value of Bcl-xL gene expression in non-small cell lung cancer.
    Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Korobowicz E; Korszen-Pilecka I; Zdunek M
    Lung Cancer; 2006 Jan; 51(1):61-9. PubMed ID: 16297499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of bcl-2 and p16 in transitional cell carcinoma of urinary bladder].
    Leng J; Zhang Y; Yao X; Wen K
    Zhonghua Wai Ke Za Zhi; 2000 Jan; 38(1):40-3. PubMed ID: 11831985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of STAT5 and Bcl-xL, and high expression of Neu and STAT3 in non-small-cell lung carcinoma.
    Sánchez-Ceja SG; Reyes-Maldonado E; Vázquez-Manríquez ME; López-Luna JJ; Belmont A; Gutiérrez-Castellanos S
    Lung Cancer; 2006 Nov; 54(2):163-8. PubMed ID: 16959370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation therapy induced changes in apoptosis and its major regulatory proteins, Bcl-2, Bcl-XL, and Bax, in locally advanced invasive squamous cell carcinoma of the cervix.
    Adhya AK; Srinivasan R; Patel FD
    Int J Gynecol Pathol; 2006 Jul; 25(3):281-7. PubMed ID: 16810067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study.
    Abdel Raheem AM; Hameed DA; ElGanainy EO; Mosad E; Abdelwanis ME; Kamel NA; Hammouda HM; Abdelaziz MA; Hemeyda K
    BMC Cancer; 2011 Jan; 11():16. PubMed ID: 21226954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in t1 urothelial urinary bladder carcinoma?
    Soukup V; Babjuk M; Dusková J; Pesl M; Szakáczová M; Zámecník L; Dvorácek J
    Urol Int; 2008; 80(4):413-8. PubMed ID: 18587253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profile in squamous cell carcinoma of the urinary bladder using complementary deoxyribonucleic acid microarray.
    Ewis AA; El-Samman E; Ali N; Kajimoto K; Shinohara Y; Ishikawa M; Kanayama HO; Baba Y
    Urol Oncol; 2007; 25(2):120-7. PubMed ID: 17349526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation of clusterin expression to prognosis of bladder carcinoma].
    Luo JH; Xie D; Chen W; Dai YP; Li XF; Tao Y; Zheng KL
    Ai Zheng; 2005 Jun; 24(6):743-7. PubMed ID: 15946493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Bcl-xL, Bax, and p53 in primary tumors and lymph node metastases in oral squamous cell carcinoma.
    Baltaziak M; Duraj E; Koda M; Wincewicz A; Musiatowicz M; Kanczuga-Koda L; Szymanska M; Lesniewicz T; Musiatowicz B
    Ann N Y Acad Sci; 2006 Dec; 1090():18-25. PubMed ID: 17384243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of antiapoptotic gene of oral carcinoma by using Bcl-2 oncogene.
    Kummoona R; Mohammad Sámi S; Al-Kapptan I; Al-Muala H
    J Oral Pathol Med; 2008 Jul; 37(6):345-51. PubMed ID: 18248353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression.
    Youssef R; Kapur P; Kabbani W; Shariat SF; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y
    BJU Int; 2011 Jul; 108(1):31-7. PubMed ID: 21105986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of antisense Bcl-2 oligonucleotides on Bcl-2 protein expression and apoptosis in human bladder transitional cell carcinoma.
    Duggan BJ; Maxwell P; Kelly JD; Canning P; Anderson NH; Keane PF; Johnston SR; Williamson KE
    J Urol; 2001 Sep; 166(3):1098-105. PubMed ID: 11490306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis-associated markers and clinical outcome in human oral squamous cell carcinomas.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Yamamoto E
    J Oral Pathol Med; 2008 Jul; 37(6):364-71. PubMed ID: 18410312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss expression of uroplakin III is associated with clinicopathologic features of aggressive bladder cancer.
    Matsumoto K; Satoh T; Irie A; Ishii J; Kuwao S; Iwamura M; Baba S
    Urology; 2008 Aug; 72(2):444-9. PubMed ID: 18313120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markers of apoptosis in stage IB squamous cervical carcinoma.
    Van de Putte G; Holm R; Lie AK; Baekelandt M; Kristensen GB
    J Clin Pathol; 2005 Jun; 58(6):590-4. PubMed ID: 15917408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of bladder cancer patients at risk for recurrence or progression: an immunohistochemical study based on the expression of metallothionein.
    Hinkel A; Schmidtchen S; Palisaar RJ; Noldus J; Pannek J
    J Toxicol Environ Health A; 2008; 71(13-14):954-9. PubMed ID: 18569601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.